Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
8.24
Dollar change
-2.31
Percentage change
-21.90
%
Index- P/E- EPS (ttm)-13.72 Insider Own30.79% Shs Outstand8.41M Perf Week-14.61%
Market Cap69.30M Forward P/E- EPS next Y- Insider Trans1.27% Shs Float5.82M Perf Month-16.60%
Income-14.80M PEG- EPS next Q- Inst Own1.37% Short Float0.16% Perf Quarter-48.45%
Sales0.14M P/S494.99 EPS this Y- Inst Trans-3.08% Short Ratio0.72 Perf Half Y-29.85%
Book/sh5.07 P/B1.63 EPS next Y- ROA-194.70% Short Interest0.01M Perf Year-63.39%
Cash/sh0.04 P/C203.82 EPS next 5Y- ROE- 52W Range7.86 - 35.17 Perf YTD-39.15%
Dividend Est.- P/FCF- EPS past 5Y-12.67% ROI-240.23% 52W High-76.57% Beta1.05
Dividend TTM- Quick Ratio0.13 Sales past 5Y-39.80% Gross Margin-20.42% 52W Low4.83% ATR (14)1.59
Dividend Ex-Date- Current Ratio0.13 EPS Y/Y TTM-41.47% Oper. Margin-7014.08% RSI (14)40.97 Volatility24.36% 14.54%
Employees4 Debt/Eq0.80 Sales Y/Y TTM317.65% Profit Margin-10424.65% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.13 EPS Q/Q-27.85% Payout- Rel Volume10.45 Prev Close10.55
Sales Surprise- EPS Surprise- Sales Q/Q600.00% Earnings- Avg Volume12.54K Price8.24
SMA20-17.58% SMA50-17.36% SMA200-48.36% Trades Volume131,049 Change-21.90%
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey GregoryDirectorMay 30 '24Buy9.505,20549,44820,206May 31 04:18 PM
Bailey GregoryDirectorMay 29 '24Buy9.501,17311,14415,001May 31 04:18 PM
Bailey GregoryDirectorMay 28 '24Buy9.509,01985,68013,828May 29 04:15 PM
Bailey GregoryDirectorMay 23 '24Buy9.502,37122,5244,809May 24 04:15 PM
MINTZ STEVENDirectorMay 21 '24Buy9.939,15190,8859,900May 23 05:07 PM
Bailey GregoryDirectorMay 21 '24Buy9.501,42213,5091,522May 23 04:15 PM
Bailey GregoryDirectorMay 21 '24Buy9.509168,7022,438May 24 04:15 PM
MINTZ STEVENDirectorMay 20 '24Buy9.432,67525,2331,240May 23 05:07 PM
Bailey GregoryDirectorMay 20 '24Buy9.00100900100May 22 04:15 PM
MINTZ STEVENDirectorMay 17 '24Buy8.505544,709554May 23 05:07 PM